Nitric Oxide Patent Expiration
Nitric Oxide is Used for treating pulmonary hypertension or hypoxia through nitric oxide delivery to the patient. It was first introduced by Mallinckrodt Hosp Products Ip Ltd
Nitric Oxide Patents
Given below is the list of patents protecting Nitric Oxide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Genosyl | US11672938 | Start-up protocols for nitric oxide delivery device | Jul 22, 2040 | Vero Biotech Inc |
| Inomax |
US9770570 (Pediatric) | Apparatus and method for monitoring nitric oxide delivery | Nov 03, 2036 | Mallinckrodt Hosp |
| Inomax | US9770570 | Apparatus and method for monitoring nitric oxide delivery | May 03, 2036 | Mallinckrodt Hosp |
| Genosyl | US10213572 | Nitrogen dioxide storage cassette | Feb 12, 2036 | Vero Biotech Inc |
| Genosyl | US10737051 | Nitrogen dioxide storage device | Oct 20, 2035 | Vero Biotech Inc |
| Inomax |
US9279794 (Pediatric) | Systems and methods for compensating long term sensitivity drift of electrochemical gas sensors exposed to nitric oxide | Aug 19, 2034 | Mallinckrodt Hosp |
| Inomax | US9279794 | Systems and methods for compensating long term sensitivity drift of electrochemical gas sensors exposed to nitric oxide | Feb 19, 2034 | Mallinckrodt Hosp |
| Inomax |
US8291904 (Pediatric) | Gas delivery device and system | Jul 06, 2031 | Mallinckrodt Hosp |
| Inomax |
US8573209 (Pediatric) | Gas delivery device and system | Jul 06, 2031 | Mallinckrodt Hosp |
| Inomax |
US8573210 (Pediatric) | Nitric oxide delivery device | Jul 06, 2031 | Mallinckrodt Hosp |
| Inomax |
US8776794 (Pediatric) | Nitric oxide delivery device | Jul 06, 2031 | Mallinckrodt Hosp |
| Inomax |
US8776795 (Pediatric) | Gas delivery device and system | Jul 06, 2031 | Mallinckrodt Hosp |
| Inomax |
US9265911 (Pediatric) | Gas delivery device and system | Jul 06, 2031 | Mallinckrodt Hosp |
| Inomax |
US9295802 (Pediatric) | Gas delivery device and system | Jul 06, 2031 | Mallinckrodt Hosp |
| Inomax |
US9408993 (Pediatric) | Nitric oxide delivery device | Jul 06, 2031 | Mallinckrodt Hosp |
| Inomax | US8291904 | Gas delivery device and system | Jan 06, 2031 | Mallinckrodt Hosp |
| Inomax | US8573209 | Gas delivery device and system | Jan 06, 2031 | Mallinckrodt Hosp |
| Inomax | US8573210 | Nitric oxide delivery device | Jan 06, 2031 | Mallinckrodt Hosp |
| Inomax | US8776794 | Nitric oxide delivery device | Jan 06, 2031 | Mallinckrodt Hosp |
| Inomax | US8776795 | Gas delivery device and system | Jan 06, 2031 | Mallinckrodt Hosp |
| Inomax | US9265911 | Gas delivery device and system | Jan 06, 2031 | Mallinckrodt Hosp |
| Inomax | US9295802 | Gas delivery device and system | Jan 06, 2031 | Mallinckrodt Hosp |
| Inomax | US9408993 | Nitric oxide delivery device | Jan 06, 2031 | Mallinckrodt Hosp |
| Genosyl | US8607785 | Systems and devices for generating nitric oxide | Jul 14, 2030 | Vero Biotech Inc |
| Genosyl | US11103669 | Nitric oxide therapies | Jun 21, 2030 | Vero Biotech Inc |
| Inomax |
US8282966 (Pediatric) | Methods of reducing the risk of occurrence of pulmonary edema in children in need of treatment with inhaled nitric oxide | Dec 30, 2029 | Mallinckrodt Hosp |
| Inomax |
US8293284 (Pediatric) | Methods of reducing the risk of occurrence of pulmonary edema in term or near-term neonates in need of treatment with inhaled nitric oxide | Dec 30, 2029 | Mallinckrodt Hosp |
| Inomax |
US8431163 (Pediatric) | Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas | Dec 30, 2029 | Mallinckrodt Hosp |
| Inomax |
US8795741 (Pediatric) | Methods for treating patients who are candidates for inhaled nitric oxide treatment | Dec 30, 2029 | Mallinckrodt Hosp |
| Inomax |
US8846112 (Pediatric) | Methods of distributing a pharmaceutical product comprising nitric oxide gas for inhalation | Dec 30, 2029 | Mallinckrodt Hosp |
| Inomax |
US11931377 (Pediatric) | Methods of administering inhaled nitric oxide gas | Dec 03, 2029 | Mallinckrodt Hosp |
| Genosyl | US11511252 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | Sep 21, 2029 | Vero Biotech Inc |
| Genosyl | US10926054 | Systems and devices for generating nitric oxide | Aug 13, 2029 | Vero Biotech Inc |
| Genosyl | US8944049 | Systems and devices for generating nitric oxide | Aug 13, 2029 | Vero Biotech Inc |
| Genosyl | US9604028 | Systems and devices for generating nitric oxide | Aug 13, 2029 | Vero Biotech Inc |
| Inomax | US8282966 | Methods of reducing the risk of occurrence of pulmonary edema in children in need of treatment with inhaled nitric oxide | Jun 30, 2029 | Mallinckrodt Hosp |
| Inomax | US8293284 | Methods of reducing the risk of occurrence of pulmonary edema in term or near-term neonates in need of treatment with inhaled nitric oxide | Jun 30, 2029 | Mallinckrodt Hosp |
| Inomax | US8431163 | Methods of reducing the risk of occurrence of pulmonary edema associated with inhalation of nitric oxide gas | Jun 30, 2029 | Mallinckrodt Hosp |
| Inomax | US8795741 | Methods for treating patients who are candidates for inhaled nitric oxide treatment | Jun 30, 2029 | Mallinckrodt Hosp |
| Inomax | US8846112 | Methods of distributing a pharmaceutical product comprising nitric oxide gas for inhalation | Jun 30, 2029 | Mallinckrodt Hosp |
| Inomax | US11931377 | Methods of administering inhaled nitric oxide gas | Jun 03, 2029 | Mallinckrodt Hosp |
| Genosyl | US9701538 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | Jan 28, 2029 | Vero Biotech Inc |
| Genosyl | US7560076 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | Apr 21, 2027 | Vero Biotech Inc |
| Genosyl | US7618594 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | Oct 17, 2026 | Vero Biotech Inc |
| Genosyl | US7947227 | Kit for the conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | Oct 17, 2026 | Vero Biotech Inc |
| Genosyl | US8057742 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | Jan 18, 2026 | Vero Biotech Inc |
| Genosyl | US10814092 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | Oct 17, 2025 | Vero Biotech Inc |
| Genosyl | US10124142 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | Aug 18, 2025 | Vero Biotech Inc |
| Genosyl | US11291793 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | Aug 18, 2025 | Vero Biotech Inc |
| Genosyl | US11383059 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | Aug 18, 2025 | Vero Biotech Inc |
| Genosyl | US11554241 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | Aug 18, 2025 | Vero Biotech Inc |
| Genosyl | US8226916 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | Aug 18, 2025 | Vero Biotech Inc |
| Genosyl | US8609028 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | Aug 18, 2025 | Vero Biotech Inc |
| Genosyl | US8821801 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | Aug 18, 2025 | Vero Biotech Inc |
| Genosyl | US9522249 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | Aug 18, 2025 | Vero Biotech Inc |
| Genosyl | US9956373 | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) | Aug 18, 2025 | Vero Biotech Inc |
| Genosyl | US6758214 | Simple nitric oxide generator for ambulatory and/or bedside inhaled no treatment |
Feb 23, 2022
(Expired) | Vero Biotech Inc |
| Inomax |
US6125846 (Pediatric) | Purge system for nitric oxide administration apparatus |
Nov 16, 2017
(Expired) | Mallinckrodt Hosp |
| Inomax |
US5732693 (Pediatric) | Pause control of nitric oxide therapy |
Jun 13, 2017
(Expired) | Mallinckrodt Hosp |
| Inomax |
US5752504 (Pediatric) | System for monitoring therapy during calibration |
Jun 13, 2017
(Expired) | Mallinckrodt Hosp |
| Inomax | US6125846 | Purge system for nitric oxide administration apparatus |
May 16, 2017
(Expired) | Mallinckrodt Hosp |
| Inomax | US5732693 | Pause control of nitric oxide therapy |
Dec 13, 2016
(Expired) | Mallinckrodt Hosp |
| Inomax | US5752504 | System for monitoring therapy during calibration |
Dec 13, 2016
(Expired) | Mallinckrodt Hosp |
| Inomax |
US5558083 (Pediatric) | Nitric oxide delivery system |
May 22, 2014
(Expired) | Mallinckrodt Hosp |
| Inomax | US5558083 | Nitric oxide delivery system |
Nov 22, 2013
(Expired) | Mallinckrodt Hosp |
| Inomax |
US5485827 (Pediatric) | Methods and devices for treating plumonary vasoconstriction and asthma |
Jul 23, 2013
(Expired) | Mallinckrodt Hosp |
| Inomax |
US5873359 (Pediatric) | Methods and devices for treating pulmonary vasoconstriction and asthma |
Jul 23, 2013
(Expired) | Mallinckrodt Hosp |
| Inomax | US5485827 | Methods and devices for treating plumonary vasoconstriction and asthma |
Jan 23, 2013
(Expired) | Mallinckrodt Hosp |
| Inomax | US5873359 | Methods and devices for treating pulmonary vasoconstriction and asthma |
Jan 23, 2013
(Expired) | Mallinckrodt Hosp |
Nitric Oxide's Family Patents
Explore Our Curated Drug Screens
Nitric Oxide Generic API Manufacturers
Several generic applications have been filed for Nitric Oxide. The first generic version for Nitric Oxide was by Linde Gas And Equipment Inc and was approved on Oct 2, 2018. And the latest generic version is by Airgas Therapeutics Llc and was approved on Jul 27, 2023.
Given below is the list of companies who have filed for Nitric Oxide generic, along with the locations of their manufacturing plants worldwide.
1. AIRGAS THERAP
Airgas Therapeutics Llc has filed for 1 generic for Nitric Oxide. This 800ppm version comes by the name ULSPIRA. Given below are the details of the strengths of this generic introduced by Airgas Therap.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 800PPM | gas | Prescription | INHALATION | AA | Jul 27, 2023 |
Manufacturing Plant Locations New
Airgas Therap's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Airgas Therap as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
2. LINDE GAS EQUIP
Linde Gas And Equipment Inc has filed for 2 different strengths of generic version for Nitric Oxide. All of these versions come by the name NOXIVENT. Given below are the details of the strengths of this generic introduced by Linde Gas Equip.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100PPM
(reference standard) | gas | Prescription | INHALATION | N/A | Oct 2, 2018 |
| 800PPM | gas | Prescription | INHALATION | AA | Oct 2, 2018 |
Manufacturing Plant Locations New
Linde Gas Equip's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Linde Gas Equip as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||